Product information and disease descriptionProduct descriptionProduct information
Pharmacology
18 evidence topics · 8 sources
First-line metastatic uveal melanoma, in combination with crizotinib
Product information and disease descriptionProduct descriptionProduct information
18 evidence topics · 8 sources